Top Vaccines companies in United States by EBITDA Margin

This ranking features the top 120 Vaccines companies in United States ranked by EBITDA Margin, averaging a EBITDA Margin of -6,900.10%, for February 04, 2025.

United States

Vaccines

#	Name	EBITDA Margin	Reported Date	Stock Price	Change	Country
1	SIGA Technologies, Inc. 1 SIGA	60.43%	Sept. 30, 2024	USD 5.78	-3.34%	United States
2	United Therapeutics Corporation 2 UTHR	54.69%	Sept. 30, 2024	USD 354.58	0.97%	United States
3	Protagonist Therapeutics, Inc. 3 PTGX	46.76%	Sept. 30, 2024	USD 37.20	-1.59%	United States
4	Zoetis Inc. 4 ZTS	42.08%	Sept. 30, 2024	USD 171.94	0.61%	United States
5	Regeneron Pharmaceuticals, Inc. 5 REGN	34.89%	Sept. 30, 2024	USD 666.85	-0.91%	United States
6	Biogen Inc. 6 BIIB	30.78%	Sept. 30, 2024	USD 142.34	-1.10%	United States
7	Merck & Co., Inc. 7 MRK	30.33%	Sept. 30, 2024	USD 99.79	0.98%	United States
8	Entrada Therapeutics, Inc. 8 TRDA	27.62%	Sept. 30, 2024	USD 13.33	-0.82%	United States
9	Abbott Laboratories 9 ABT	26.09%	Sept. 30, 2024	USD 128.45	0.41%	United States
10	ADMA Biologics, Inc. 10 ADMA	25.73%	Sept. 30, 2024	USD 16.47	1.98%	United States
11	Thermo Fisher Scientific Inc. 11 TMO	24.39%	Dec. 31, 2024	USD 593.75	-0.67%	United States
12	Charles River Laboratories International, Inc. 12 CRL	24.39%	Sept. 28, 2024	USD 161.62	-1.91%	United States
13	Pfizer Inc. 13 PFE	23.01%	Sept. 29, 2024	USD 26.20	-1.21%	United States
14	Dynavax Technologies Corporation 14 DVAX	14.82%	Sept. 30, 2024	USD 12.94	-0.84%	United States
15	Gilead Sciences, Inc. 15 GILD	13.85%	Sept. 30, 2024	USD 98.38	1.21%	United States
16	Laboratory Corporation of America Holdings 16 LH	11.13%	Sept. 30, 2024	USD 247.86	-0.78%	United States
17	Bristol-Myers Squibb Company 17 BMY	10.66%	Sept. 30, 2024	USD 59.95	1.70%	United States
18	DLH Holdings Corp. 18 DLHC	10.50%	Sept. 30, 2024	USD 7.39	-1.47%	United States
19	Phibro Animal Health Corporation 19 PAHC	10.20%	Sept. 30, 2024	USD 21.69	-0.55%	United States
20	Emergent BioSolutions Inc. 20 EBS	2.11%	Sept. 30, 2024	USD 10.49	-6.76%	United States
21	Radius Recycling, Inc. 21 RDUS	1.14%	Nov. 30, 2023	USD 11.89	0.59%	United States
22	Exact Sciences Corporation 22 EXAS	0.98%	Sept. 30, 2024	USD 55.24	-1.44%	United States
23	Cytek Biosciences, Inc. 23 CTKB	-2.63%	Sept. 30, 2024	USD 5.39	4.66%	United States
24	Alnylam Pharmaceuticals, Inc. 24 ALNY	-6.25%	Sept. 30, 2024	USD 274.55	1.19%	United States
25	BioCryst Pharmaceuticals, Inc. 25 BCRX	-6.69%	Sept. 30, 2024	USD 7.62	-3.54%	United States
26	Cumberland Pharmaceuticals Inc. 26 CPIX	-10.59%	Sept. 30, 2024	USD 2.13	-5.75%	United States
27	Vanda Pharmaceuticals Inc. 27 VNDA	-15.80%	Sept. 30, 2024	USD 4.31	-2.27%	United States
28	OPKO Health, Inc. 28 OPK	-16.72%	June 30, 2024	USD 1.50	-1.32%	United States
29	Amylyx Pharmaceuticals, Inc. 29 AMLX	-20.12%	March 31, 2024	USD 3.42	-6.30%	United States
30	Exagen Inc. 30 XGN	-23.08%	Sept. 30, 2024	USD 3.88	-3.00%	United States
31	Novavax, Inc. 31 NVAX	-24.44%	Sept. 30, 2024	USD 8.43	-2.99%	United States
32	Applied BioCode Corporation 32 6598.TW	-24.95%	Dec. 31, 2023	USD 0.69	NA	United States
33	Apellis Pharmaceuticals, Inc. 33 APLS	-29.32%	Sept. 30, 2024	USD 28.49	-1.79%	United States
34	Ionis Pharmaceuticals, Inc. 34 IONS	-31.45%	Sept. 30, 2024	USD 32.13	0.72%	United States
35	Quanterix Corporation 35 QTRX	-32.43%	Sept. 30, 2024	USD 8.83	-3.92%	United States
36	Y-mAbs Therapeutics, Inc. 36 YMAB	-32.96%	Sept. 30, 2024	USD 5.80	-2.85%	United States
37	BioLife Solutions, Inc. 37 BLFS	-36.16%	March 31, 2024	USD 26.62	-2.53%	United States
38	Moderna, Inc. 38 MRNA	-40.74%	Sept. 30, 2024	USD 36.55	-7.28%	United States
39	Arcturus Therapeutics Holdings Inc. 39 ARCT	-40.75%	Sept. 30, 2024	USD 15.80	-6.89%	United States
40	Biodesix, Inc. 40 BDSX	-45.18%	Sept. 30, 2024	USD 1.01	-1.94%	United States
41	Cryoport, Inc. 41 CYRX	-54.61%	Sept. 30, 2024	USD 7.38	-2.12%	United States
42	MacroGenics, Inc. 42 MGNX	-63.04%	Sept. 30, 2024	USD 2.85	-5.00%	United States
43	Guardant Health, Inc. 43 GH	-67.45%	Sept. 30, 2024	USD 47.57	1.26%	United States
44	Dyadic International, Inc. 44 DYAI	-82.96%	Sept. 30, 2024	USD 1.46	-2.01%	United States
45	HOOKIPA Pharma Inc. 45 HOOK	-83.67%	Sept. 30, 2024	USD 1.91	-2.55%	United States
46	Pulmatrix, Inc. 46 PULM	-87.93%	June 30, 2024	USD 7.50	-2.60%	United States
47	Axsome Therapeutics, Inc. 47 AXSM	-88.81%	Sept. 30, 2024	USD 107.43	0.91%	United States
48	Adaptive Biotechnologies Corporation 48 ADPT	-92.23%	Sept. 30, 2024	USD 7.70	-0.65%	United States
49	Agenus Inc. 49 AGEN	-93.35%	Dec. 31, 2023	USD 3.51	-7.63%	United States
50	Arcus Biosciences, Inc. 50 RCUS	-96.96%	Sept. 30, 2024	USD 13.20	2.33%	United States

1 2 3

Frequently Asked Questions

Which Vaccines company in United States has the highest EBITDA Margin ?

The Vaccines company in United States with the highest EBITDA Margin is SIGA Technologies, Inc. (NasdaqGM: SIGA) at 60.43%.
Which Vaccines company in United States has the lowest EBITDA Margin ?

The Vaccines company in United States with the lowest EBITDA Margin is Greenwich LifeSciences, Inc. (NasdaqCM: GLSI) at -198,598.69%.

What are the top 10 Vaccines companies in United States by EBITDA Margin ?

The top 10 Vaccines companies in United States by EBITDA Margin are SIGA Technologies, Inc., United Therapeutics Corporation, Protagonist Therapeutics, Inc., Zoetis Inc., Regeneron Pharmaceuticals, Inc., Biogen Inc., Merck & Co., Inc., Entrada Therapeutics, Inc., Abbott Laboratories and ADMA Biologics, Inc..
What are the bottom 10 Vaccines companies in United States by EBITDA Margin ?

The bottom 10 Vaccines companies in United States by EBITDA Margin are Greenwich LifeSciences, Inc., Acelyrin, Inc., Altimmune, Inc., 89bio, Inc., Revolution Medicines, Inc., Akero Therapeutics, Inc., AN2 Therapeutics, Inc., Galectin Therapeutics Inc., Kala Pharmaceuticals, Inc. and Gain Therapeutics, Inc..

Frequently Asked Questions

Don’t Miss A Beat